All Products are stable to be shipped at room temperature, unless otherwise specified.
| Pack Size | Quantity | Price (USD) | Sub Total |
|---|---|---|---|
| 10mg | $ 98.00 | 0.0 | |
| 50mg | $ 161.00 | 0.0 | |
| 100mg | $ 221.00 | 0.0 | |
| 500mg | $ 640.00 | 0.0 | |
| Exact Weight Packaging | $ 145.00 | 0.0 | |
| Total | $ 0.0 | ||
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : In Stock
- Ships On :
A112425
Bulk Order Request for A112425
Product Description
| Catalogue Number | A112425 |
| Chemical Name | ABT 199 (>99%)(Venetoclax) |
| Synonyms | 4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide |
| CAS Number | 1257044-40-8 |
| Molecular Formula | C₄₅H₅₀ClN₇O₇S |
| Appearance | Pale Yellow to Light Yellow Solid |
| Melting Point | >150°C (dec.) |
| Molecular Weight | 868.44 |
| Storage | -20°C |
| Solubility | DMSO (Slightly) |
| Category | Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | ABT 199 (>99%) is a potent and selective BCL-2 inhibitor that achieves potent antitumour activity while sparing platelets. It’s practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer. |
| References | Davids, M. & Letai, A.: Cancer Cell, 23, 139 (2013); Souers, A.,et al.: Nat. Med., 19, 202 (2013); Vaillant, F., et al.: Cancer Cell, 24, 120 (2013); Vogler, M., et al.: Brit. J. Haematol., 163, 139 (2013); |